ÂÜÀòÂÒÂ×

Andres Brainsky is an experienced clinical development leader with a focus on hematology. Currently serving as Vice President of Clinical Development at CSL since July 2024, Brainsky has held prominent roles in various organizations including CSL Behring and Aileron Therapeutics, where responsibilities included oversight of global clinical programs and trial design across multiple phases. With a strong background in oncology and pediatric clinical development during tenure at GlaxoSmithKline, Brainsky has successfully managed pediatric clinical programs, engaging with regulatory agencies for study approvals. Academic qualifications include a Doctor of Medicine and Surgery from Pontificia Universidad Javeriana and a Pediatric Surgeon degree from Universidad Nacional de Colombia, along with a United States Board Certified Physician certification issued in February 2009.